Guest Editors
Sumel Ashique
Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences & Research
Sumel Ashique serves as an Assistant Professor at Bengal College of Pharmaceutical Sciences & Research, West Bengal, India, with four years of teaching experience. He has contributed 80 publications to internationally and nationally recognized journals. His expertise lies in drug delivery, nanotechnology, gut-microbiota, and biotics. Sumel Ashique is an esteemed reviewer for various prestigious publishers including Elsevier, Springer, MDPI, Wiley, Dove Press, and Bentham Science. He holds five granted patents from IP Australia and has authored 25 book chapters published by Bentham, Springer, Elsevier, and Taylor & Francis. Currently, he has edited seven books under CRC Press, Taylor & Francis, Wiley, Nova Science, and Springer, and serves as a guest editor for several journals.
Shakira Ghazanfar
National Institute for Genomics Advanced Biotechnology & NARC
Shakira Ghazanfar, a renowned microbiologist and expert in probiotics, has made substantial contributions to microbiology, particularly in the advancement of probiotics for humans and animals. She obtained her PhD in Microbiology from Quaid-i-Azam University, specializing in gut microbial genomics and probiotic products. Since 2007, Dr. Ghazanfar has served as a Senior Scientific Officer at the Pakistan Agricultural Research Council (PARC), where she played a crucial role in establishing the Probiotic Development Lab in Islamabad. Her AI-based probiotic innovations have been widely applied in sectors such as animal feed and human nutrition.Dr. Ghazanfar is acclaimed for developing "Probio Predict," a bioinformatics tool that forecasts outcomes of probiotic products. She has supervised over 70 graduate students and contributed to numerous research projects funded by various organizations, aiming to enhance health and productivity through microbial genomics. With a portfolio of over 100 research papers, she has also served as an editor for multiple scientific publications. In recognition of her achievements, Dr. Ghazanfar was honored with the Young Biotechnology Award in 2021 by the Society for Uplifting of Rural Areas in India. She remains a prominent figure in microbiology, actively working on projects to improve agricultural practices and livestock productivity in Pakistan
Collection Overview
In recent years, microbiome studies have significantly advanced our knowledge of how human health is influenced by trillions of microbes residing in the body. This discovery has led to innovations in ‘Biotics’ (probiotics, prebiotics, postbiotics, and para probiotics). As research progresses, a new field, Biotics, emerges. The Biotics market is growing rapidly due to increased awareness of gut health benefits. Probiotics, prebiotics, and synbiotics are all considered Biotics, influencing health through dietary means.
This collection aims to enhance understanding of how Biotics and Gut-Microbiota impact various metabolic pathways and can potentially revolutionize disease treatments. It also focuses on the beneficial roles and safe applications of these viable and non-viable microorganisms. Their stability, extended shelf life, and effectiveness in gut healing, without the complications associated with live bacteria, make them appealing for consumers and businesses. The aim of proposing this collection is to bridge basic science and clinical practice, providing translational insights into how manipulating gut microbiota with Biotic interventions can be applied in clinical settings for managing human diseases? It offers a comprehensive analysis of gut microbiota and Biotics' health benefits, including recent data, key concepts, and practical implications.
The primary audience for methods collection includes health professionals, clinician-scientists, and translational researchers involved in gut microbiome research or clinical studies targeting gut microbiome manipulation. Specializations such as gastroenterology, oncology, microbiology, food technology, and related fields will find detailed exploration of the intricate relationship between gut microbiota and Biotics in human disease management, alongside comprehensive guidance on diagnosis, therapy, and future directions. This audience seeks in-depth insights, cutting-edge research, and practical applications to advance their understanding and management of human health conditions.
Articles
Abstracts
Development of a New Eukaryotic Expression Vector Based on Synthetic Biology for Gene Therapies and DNA Vaccines
Rhayane Viegas1,
Monique Americo1,
Andria Freitas1,
Luis Lima1,
Vasco Azevedo*1
1UFMG- Federal University of Minas Gerais
Enterocins-Antibiotic Synergetic Consortia: Expanding the Inhibition Spectrum Against Methicillin Resistant Staphylococcus aureus (MRSA)
Asma Bashir*1
1SZABIST University
Temporal Disruption and Recovery of Gut Microbiota During Chemotherapy: 16S rRNA-based microbiota profiling
Cihat ÖZTÜRK*1,
Süleyman YALÇIN2,
Sadık KÜÇÜKGÜNAY3,
Hakan Farzin Mehmetzade4,
Memiş BOLACALI5,
Elif SEVİM6
1Kırşehir Ahi Evran University, Deparment of Medical Microbiology, Faculty of Medicine, Kırşehir, Turkiye.,
2Turkish Public Health Directorate General Molecular Microbiology Reference Laboratory, Ankara, Turkiye.,
3Kırşehir Ahi Evran University, Deparment of Pharmacology, Faculty of Medicine, Kırşehir, Turkiye.,
4Directorate General of Public Health, Departme, Directorate General of Public Health, Medical Microbiology Reference Laboratory, Ankara, Turkiye.,
5Kırşehir Ahi Evran University, Deparment of Biostatistics and Medical Informatics, Faculty of Medicine, Kırşehir, Turkiye.,
6Kırşehir Ahi Evran University, Department of Medical Biology, Faculty of Medicine, Kırşehir, Turkiye.